联系方式：电话：**； E-mail: manruojun@163.com
简介：
满若君，女，1981年7月出生，黑龙江哈尔滨人，博士（生物学专业），助理研究员。目前从事《中药学》、《中药制药工艺学》与《药品生产质量管理工程》三门本科生课程的教学工作。科研方向为药物化学（靶向抗肿瘤药物的小分子抑制剂的合成等）。在SCI期刊上发表论文多篇。

研究领域：
主要从事药物化学的研究———靶向抗肿瘤药物的小分子抑制剂的合成等。

近五年公开发表论文情况：
1. Ruo-Jun Man, Long-Wang Chen, Hai-Liang Zhu. Telomerase inhibitors: a patent review (2010–2015). Expert opinion on therapeutic patents. 2016, 22:6, 679-688.（IF=4.378药学二区）
2. Ruo-Jun Man, Dan-Jie Tang, Xiao-Yuan Lu, Yong-Tao Duan, Xiang-Xiang Tao, Meng-Ru Yang, Le-Le Wang, Bao-Zhong Wang, Chen Xu and Hai-Liang Zhu. Synthesis and biological evaluation of novel indole derivatives containing sulfonamide scaffold as potential tubulin inhibitor. MedChemComm. 2016, 7, 1759-1767.（IF=2.608医学三区）
3.Yong-Tao Duan＊, Ruo-Jun Man＊, Dan-Jie Tang＊, Yong-Fang Yao, Xiang-Xiang Tao, Chen Yu, Xin-Yi Liang, Jigar A. Makawana1, Mei-Juan Zou, Zhong-Chang Wang, Hai-Liang Zhu. Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents. Scientific reports 2016, doi: 10.1038/srep25387. （IF=4.259医学综合二区）
4. Long-Wang Chen, Ze-Feng Wang, Bo Zhu, Ruo-Jun Man, Yan-Dong Liu, Yuan-Heng Zhang, Bao-Zhong Wang, Zhong-Chang Wang, Hai-Liang Zhu. Design, synthesis and biological evaluation of novel benzo-a-pyrone containing piperazine derivatives as potential BRAF^V600E inhibitors. Bioorganic & Medicinal Chemistry Letters. 2016, 20: 4, 254-263.（IF=2.454药物化学三区）
5. Long-Wang Chen, Peng-Fei Wang, Dan-Jie Tang, Xiang-Xiang Tao, Ruo-Jun Man, Han-Yue Qiu, Zhong-Chang Wang, Chen Xu, Hai-Liang Zhu. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation. Chem Biol Drug Des. 2016, 88: 592-598.（IF=2.396医学三区）
6. Xiao-Yuan Lu, Zhong-Chang Wang, Shen-Zhen Ren, Fa-Qian Shen, Ruo-Jun Man, Hai-Liang Zhu. Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis. Bioorganic & Medicinal Chemistry Letters. 2016, 16: 22, 3491-3498.（IF=2.454药物化学三区）